Adaptive Immunity Part 2 - B Cell Response

1. Fundamentals of Immunity and Host Defense

• Definition of Immunity: Biological defense mechanism that protects the host organism from infection by pathogens.

• Multilayered Immune System:

  • Innate Immunity: Natural built-in system, rapid response (hours), non-specific, no immunological memory. Includes physical/chemical barriers, cellular components, and humoral factors.

  • Adaptive Immunity: Acquired system, slower initial response (days to weeks), highly antigen-specific, develops long-lasting immunological memory. Present only in vertebrates.

• Oral Cavity as a First-Line Barrier:

  • Saliva: Contains lysozymes (cleave bacterial cell walls), defensins, and secreted $ext{IgA}$ (prevents bacterial plaque formation).

  • Gingival Crevicular Fluid (GCF): Exudate in the gingival sulcus containing complement components, antibodies ($ext{IgG}$), neutrophils, and plasma cells.

  • Clinical High-Yield: Xerostomia (dry mouth) breaks this primary natural barrier, drastically accelerating enamel loss, caries progression, and periodontal infection.

2. Innate Immunity: Cellular Components and Activation

• Neutrophils (Polymorphonuclear Leukocytes — PMNs):

  • Abundance: Most abundant circulating white blood cells, accounting for approximately $60\%$ of total leukocytes in human blood.

  • Structure & Lifespan: Segmented, multi-lobed nucleus allows high structural flexibility to squeeze through narrow endothelial gaps (extravasation). Short half-life of $8-20\,\text{hours}$ in peripheral blood and lifespan of $2-3\,\text{days}$ in tissue.

  • Extravasation Cascade: Selectins mediate weak initial rolling; Integrins ($\text{CD11b/CD18}$) mediate firm endothelial adhesion; Chemokines ($\text{IL-8}$, $\text{C5a}$) guide directional tissue migration.

  • NETosis: Activated neutrophils can undergo a specialized form of cell death releasing Neutrophil Extracellular Traps (NETs)—web-like structures composed of nuclear DNA, elastase, myeloperoxidase, and histones to trap and kill extracellular pathogens.

• Macrophages:

  • Derived from blood monocytes; possess a longer lifespan and several-fold greater phagocytic capacity than neutrophils.

  • Function both as scavengers and key Antigen-Presenting Cells (APCs).

  • Phagocytic Discrimination: Healthy host cells display "don't eat me" signals ($\text{CD47}$), while dying cells expose "eat me" signals (phosphatidylserine) recognized by macrophages.

  • Activation: Phagocytosis of bacteria and exposure to cytokines ($\text{IFN-}\gamma$) trigger activation, increasing cell size, lysosomal enzyme expression, Reactive Oxygen Species (ROS), Nitric Oxide (NO), and pro-inflammatory cytokine secretion ($\text{IL-1}\alpha$, $\text{IL-1}\beta$, $\text{TNF-}\alpha$).

3. Pattern Recognition Receptors (PRRs) and Microbial Sensing

• Pathogen-Associated Molecular Patterns (PAMPs): Conserved, invariant structural components unique to microbial classes that are essential for pathogen survival.

• Pattern Recognition Receptors (PRRs): Germline-encoded host receptors that recognize PAMPs.

• Toll-Like Receptor (TLR) Family:

  • Surface Membrane TLRs:

  • $\text{TLR4}$: Recognizes Lipopolysaccharide (LPS) on Gram-negative bacterial outer membranes. Signaling depends predominantly on the $\text{MyD88}$ adapter to activate $\text{NF-}\kappa\text{B}$.

  • $\text{TLR2}$: Recognizes peptidoglycan and lipoteichoic acid (LTA) of Gram-positive bacteria.

  • $\text{TLR1/2}$: Recognizes triple-stranded bacterial lipoproteins.

  • $\text{TLR2/6}$: Recognizes double-stranded mycoplasma lipoproteins.

  • $\text{TLR5}$: Recognizes bacterial flagellin proteins.

  • Endosomal TLRs (Sensing internalized viral/bacterial nucleic acids inside endosomes to prevent autoreactivity against extracellular host DNA/RNA):

  • $\text{TLR3}$: Recognizes double-stranded viral RNA (dsRNA); signals via $\text{TRIF}$.

  • $\text{TLR7}$: Recognizes single-stranded viral RNA (ssRNA).

  • $\text{TLR9}$: Recognizes unmethylated $\text{CpG}$ DNA motifs common in bacterial and viral genomes.

• Other PRR Families:

  • C-type Lectin Receptors (CLRs): Membrane receptors recognizing fungal cell wall glycans (e.g., $\beta\text{-glucans}$).

  • NOD-Like Receptors (NLRs) & RIG-I-Like Receptors (RLRs): Cytoplasmic sensors for intracellular peptidoglycans and viral RNA.

  • cGAS: Cytoplasmic enzyme that senses intracellular foreign DNA.

4. The Complement System

• Humoral Innate Component: System of over $30$ plasma proteins and cell-bound regulators, synthesized constitutively by the liver and circulating as inactive zymogens.

• Three Activation Pathways:

  • Classical Pathway: Activated by adaptive immune complexes ($\text{IgM}$ or aggregated $\text{IgG}$ bound to antigen). $\text{C1q}$ binds antibody Fc stems, activating $\text{C1r/C1s}$ proteases to cleave $\text{C4}$ and $\text{C2}$, forming the $\text{C4b2a}$ convertase.

  • Alternative Pathway: Antibody-independent. Continuous low-level spontaneous hydrolysis ("tick-over") of $\text{C3}$ generates $\text{C3b}$, which binds Factor B and Factor D to form $\text{C3bBb}$ convertase (stabilized by properdin). Accounts for $80\%-90\%$ of total complement activation.

  • Lectin Pathway: Mannose-Binding Lectin (MBL) or ficolins bind microbial surface mannose sugars, activating MASP proteases to form $\text{C4b2a}$ convertase.

• Effector Functions:

  • Anaphylatoxins ($\text{C3a}$, $\text{C5a}$): Induce mast cell histamine release, vasodilation, and vascular permeability. $\text{C5a}$ is a potent neutrophil chemoattractant.

  • Opsonization: Surface deposition of $\text{C3b}$ (and $\text{iC3b}$) binds Complement Receptors ($\text{CR1/CD35}$, $\text{CR3}$) on phagocytes to enhance phagocytosis.

  • Membrane Attack Complex (MAC / $\text{C5b-9}$): $\text{C5}$ convertase cleaves $\text{C5}$ into $\text{C5a}$ and $\text{C5b}$. $\text{C5b}$ sequentially recruits $\text{C6}$, $\text{C7}$, $\text{C8}$, and $10-18$ molecules of $\text{C9}$ to form a $10\,\text{nm}$ ($100\,\text{\AA}$) transmembrane pore leading to bacterial osmolysis.

5. Adaptive Immunity: T Cell Response and Cell-Mediated Immunity

• Antigen Presentation by Dendritic Cells (DCs):

  • Peripheral tissue DCs capture antigens, break proteins into peptides ($10-30$ amino acids long), load them onto Class II MHC ($\text{MHC-II}$), and upregulate chemokine receptors $\text{CCR7}$ and $\text{CXCR4}$ to migrate to draining lymph nodes via signals $\text{CCL19}$ and $\text{CCL21}$.

• Three Signals Required for Naïve T Cell Activation:

  • Signal 1: TCR engagement with the specific peptide presented on MHC.

  • Signal 2 (Co-stimulation): Binding of $\text{B7}$ ($\text{CD80/CD86}$) on APC to $\text{CD28}$ on the T cell.

  • Signal 3 (Cytokines): Local cytokine milieu secreted by APCs directing T cell lineage differentiation.

• Helper T Cell ($\text{CD4}^+$ Th) Subsets:

  • $\text{Th1}$: Induced by $\text{IL-12}$ and $\text{IFN-}\gamma$ (Master factor: $\text{T-bet}$); secretes $\text{IFN-}\gamma$, $\text{IL-2}$, $\text{TNF-}\alpha$. Engages $\text{CD40L-CD40}$ on macrophages to drive classical macrophage activation against intracellular bacteria and viruses.

  • $\text{Th2}$: Induced by $\text{IL-4}$ (Master factor: $\text{GATA3}$); secretes $\text{IL-4}$, $\text{IL-5}$, $\text{IL-13}$. Recruits eosinophils/mast cells and drives $\text{IgE}$ switching against helminths and parasites; mediates type I allergic reactions.

  • $\text{Th17}$: Induced by $\text{IL-6}$, $\text{TGF-}\beta$, $\text{IL-23}$ (Master factor: $\text{ROR}\gamma\text{t}$); secretes $\text{IL-17A}$, $\text{IL-17F}$, $\text{IL-22}$. Recruits neutrophils to clear extracellular bacteria and fungal infections.

• Cytotoxic T Cells ($\text{CD8}^+$ CTLs) and Cross-Presentation:

  • Target intracellular pathogens (viruses, obligate intracellular bacteria like Mycobacteria and Listeria).

  • MHC Class I vs Class II:

  • $\text{MHC-I}$: Expressed on all nucleated cells; presents endogenous cytoplasmic peptides ($8-11$ amino acids; closed groove ends) to $\text{CD8}^+$ CTLs.

  • $\text{MHC-II}$: Expressed only on APCs (DCs, macrophages, B cells); presents exogenous endocytosed peptides ($10-30$ amino acids; open groove ends) to $\text{CD4}^+$ Th cells.

  • Cross-Presentation: Specialized classical DCs internalize exogenous viral/tumor antigens, process them via proteasomes, and display them on $\text{MHC-I}$ to prime naïve $\text{CD8}^+$ CTLs.

  • CTL Killing Mechanism: Adheres to target cells using $\text{LFA-1/ICAM-1}$ and exocytoses granules containing perforin (punctures cell membrane) and granzymes (cleaves caspases to induce targeted apoptosis).

6. Adaptive Immunity: B Cell Response and Humoral Immunity

• B Cell Activation Pathways:

  • T Cell-Dependent Activation (Protein Antigens):

  • Naïve B cells bind protein antigen via membrane $\text{IgM}$ ($\text{BCR}$), endocytose, process, and present peptide on $\text{MHC-II}$.

  • B cells upregulate $\text{CCR7}$ and migrate to the B cell–T cell boundary in lymph nodes to meet primed $\text{CD4}^+$ Th cells expressing $\text{CXCR5}$.

  • Requires TCR-$\text{MHC-II}$ binding, $\text{CD40L-CD40}$ engagement, $\text{B7-CD28}$ co-stimulation, and helper cytokines ($\text{IL-4}$, $\text{IL-21}$).

  • T Cell-Independent Activation (Non-Protein / Repetitive Antigens):

  • Repetitive non-protein antigens (e.g., LPS O-antigen on Gram-negative bacteria) cross-link multiple surface BCRs simultaneously.

  • Requires a secondary signal (such as TLR activation).

  • Induces rapid, short-lived pentameric $\text{IgM}$ production without germinal center reactions, class switching, or memory B cell formation.

• Germinal Center (GC) Reaction:

  • Dark Zone (DZ): Rapid clonal expansion and Somatic Hypermutation (SHM) of variable regions driven by Activation-Induced Cytidine Deaminase (AID).

  • Light Zone (LZ): Selection phase where B cells test their mutated BCRs against intact antigens held by Follicular Dendritic Cells (FDCs) and receive survival signals from T follicular helper ($\text{Tfh}$) cells. High-affinity cells survive; low-affinity cells undergo apoptosis.

• Immunoglobulin Isotype Classes:

  • $\text{IgM}$: Pentamer ($970\,\text{kDa}$) joined by a J chain. $5-10\%$ of serum Ab. Primary early defense, agglutinates pathogens, strong complement activator. Shifts from planar to staple conformation upon antigen binding to expose $\text{C1q}$ docking sites.

  • $\text{IgG}$: Monomer ($150\,\text{kDa}$). $80\%$ of serum Ab. Main systemic protector. Mediates opsonization, viral/toxin neutralization, complement activation, and ADCC. Only isotype capable of crossing the placenta (passive neonatal immunity).

  • $\text{IgA}$: Dimer ($405\,\text{kDa}$) with J chain and secretory component. $10-15\%$ of serum Ab. Primary mucosal protector (saliva, tears, GCF, GI tract); neutralizes pathogens without triggering damaging inflammation.

  • $\text{IgE}$: Monomer ($190\,\text{kDa}$). $0.002\%$ of serum Ab. Binds high-affinity $\text{Fc}\epsilon\text{RI}$ receptors on mast cells and basophils; drives type I hypersensitivity (allergic reactions) and parasite destruction.

  • $\text{IgD}$: Monomer ($175\,\text{kDa}$). $0.2\%$ of serum Ab. Co-expressed with $\text{IgM}$ on the surface of naïve B cells as an antigen receptor.

7. Receptor Diversity, Tolerance, and Memory

• VDJ Somatic Recombination:

  • Resolves genetic paradox: Humans possess only $\approx 22,000-23,000$ genes but generate $>100\text{ billion}$ ($>10^{11}$) distinct BCR and TCR receptors.

  • Mediated by $\text{RAG1/RAG2}$ recombinase enzymes and $\text{TdT}$. Randomly shuffles V (Variable), D (Diversity), and J (Joining) gene segments.

  • Heavy chain ($\text{H}$) or $\beta$-chain rearranges first (D-J then V-DJ), followed by Light chain ($\text{L}$) or $\alpha$-chain (V-J).

• Thymic T Cell Selection (Central Tolerance):

  • Positive Selection (Thymic Cortex): Double-positive ($\text{CD4}^+\text{CD8}^+$) thymocytes must recognize self-MHC complexes with moderate affinity; failure leads to "death by neglect" ($85\%-90\%$ of cells).

  • Negative Selection (Thymic Medulla): Thymocytes binding self-antigens with high affinity undergo apoptosis to eliminate autoreactive cells.

  • Lineage Commitment: Recognition of $\text{MHC-I}$ yields $\text{CD8}^+$ CTLs; recognition of $\text{MHC-II}$ yields $\text{CD4}^+$ Th cells.

• B Cell Central Tolerance (Bone Marrow):

  • Autoreactive immature B cells undergo negative selection (apoptosis) or Receptor Editing (reactivating $\text{RAG}$ to swap light-chain V gene segments).

• Peripheral Tolerance Mechanisms:

  • Anergy: T or B cells recognizing antigen without co-stimulation ($\text{B7-CD28}$) or engaging checkpoint inhibitors ($\text{CTLA-4}$, $\text{PD-1}$) become functionally unresponsive.

  • Activation-Induced Cell Death (AICD): Repeated TCR stimulation upregulates surface $\text{FasL}$, engaging $\text{Fas}$ receptors on neighboring cells to trigger extrinsic apoptosis.

  • Regulatory T Cells (Tregs): Defined as $\text{CD4}^+\text{CD25}^+$ cells driven by transcription factor $\text{FOXP3}$. Secrete immunosuppressive cytokines ($\text{IL-10}$, $\text{TGF-}\beta$, $\text{IL-35}$), consume $\text{IL-2}$, and use $\text{CTLA-4}$ to downregulate $\text{B7}$ on APCs.

• Immunological Memory Dynamics:

  • Primary Response: Lag time $5-10\,\text{days}$, low peak titer, dominated by low-affinity $\text{IgM}$.

  • Secondary Response: Short lag time $1-3\,\text{days}$, $10-100\text{-fold}$ higher peak titer, dominated by high-affinity class-switched $\text{IgG}$.

  • Memory Subsets:

  • Central Memory T Cells ($\text{T}_{\text{CM}}$): Express $\text{CCR7}$; home to lymphoid organs and bone marrow survival niches ($\text{IL-7}$, $\text{IL-15}$); retain high proliferative potential.

  • Effector Memory T Cells ($\text{T}_{\text{EM}}$): Reside in peripheral mucosal tissues; provide immediate effector cytokines/cytotoxicity upon antigen re-entry.

  • Long-Lived Plasma Cells: Non-proliferating terminal B cells residing in bone marrow niches; continuously secrete high-affinity antibodies for decades without requiring antigen re-exposure.

8. High-Yield Endodontic & Dental Pathology Applications

• Normal vs. Inflamed Dental Pulp:

  • Normal pulp lacks immunoglobulin-positive cells and contains minimal serum-derived baseline $\text{IgG}$.

  • Inflamed pulp (pulpitis) shows heavy infiltration of PMNs, macrophages, lymphocytes, and plasma cells.

  • Immunoglobulin prevalence in pulpitis: $\text{IgG} > \text{IgA} > \text{IgE} > \text{IgM}$. Immunoglobulin-positive cells increase by $>30\%$ in severe cases to synthesize local antibodies against carious pathogens (P. intermedia, F. nucleatum, P. micra, S. intermedius).

• Localization of Antibodies in Dentin: In carious teeth, immunoglobulins ($\text{IgG}$, $\text{IgM}$, $\text{IgA}$) accumulate exclusively along the walls of dentinal tubules within the carious cone of dentin.

• Role of Neutrophils in Endodontics:

  • Double-edged sword: PMN enzymes (elastase, MMP-8) contribute to pulpal and periapical tissue destruction.

  • Crucial protective role: Selectin-deficient ($\text{P/E}^{-/-}$) mice unable to undergo PMN extravasation develop significantly larger periapical bone lesions. Enhancing PMN activity (e.g., via PGG-glucan) reduces periapical lesion size.

• Bone Resorption Mechanisms in Periapical Lesions:

  • Macrophage-derived pro-inflammatory cytokines ($\text{IL-1}\alpha$, $\text{IL-1}\beta$, $\text{TNF-}\alpha$) drive osteoclastogenesis and periapical bone destruction. $\text{IL-1}\beta$ is the most potent bone-resorptive cytokine.

  • $\text{TLR4}$ knockout mice develop significantly smaller periapical lesions due to markedly reduced $\text{IL-1}$ levels.

• Protective Importance of Antibodies:

  • In $\text{RAG2}$ knockout (SCID) and $\text{Igh-6}$ (B cell-deficient) mice, endodontic infections lead to severe orofacial abscesses and high mortality ($40\%-50\%$ death rate).

  • T cell-deficient mice produce modest T-independent $\text{IgM}$ and some $\text{IgG}$ subclasses, preventing systemic abscess formation and death.

  • Adoptive transfer of purified $\text{IgG}$ or immune ascites to infected $\text{RAG2}$ KO mice prevents abscess formation in up to $90\%$ of animals, proving antibodies are the indispensable factor containing endodontic infections locally to the periapices.

• Protective Role of Regulatory T Cells (Tregs):

  • $\text{FOXP3}^+$ Tregs accumulate in periapical lesions between days 7 and 21 post-infection.

  • Adoptive transfer of Tregs (antigen-specific or non-specific) significantly suppresses periapical bone destruction by releasing $\text{IL-10}$ and $\text{TGF-}\beta$, inhibiting macrophage activation and limiting neutrophil-mediated tissue damage.